Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MTCR Metacrine > Detailed Quotes

MTCR Metacrine

0.430
-0.034-7.33%
Close 09/23 16:00 ET
High
0.470
Open
0.465
Turnover
164.36K
Low
0.430
Pre Close
0.464
Volume
365.20K
Market Cap
18.30M
P/E(TTM)
Loss
52wk High
3.870
Shares
42.57M
P/E(Static)
Loss
52wk Low
0.350
Float Cap
15.21M
Bid/Ask %
-93.55%
Historical High
16.190
Shs Float
35.36M
Volume Ratio
0.83
Historical Low
0.350
Dividend TTM
--
Div Yield TTM
--
P/B
0.44
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.03%
Amplitude
8.60%
Avg Price
0.450
Lot Size
1
Float Cap
15.21M
Bid/Ask %
-93.55%
Historical High
16.190
Shs Float
35.36M
Volume Ratio
0.83
Historical Low
0.350
Dividend TTM
--
P/B
0.44
Dividend LFY
--
Turnover Ratio
1.03%
Amplitude
8.60%
Avg Price
0.450
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Metacrine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases. It offers farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.
CEO: Dr. Preston Klassen,M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...